Connect with us

Business

Tiffany’s sees recovery, as LVMH tries to dump $16B deal – Fox Business

Tiffany & Co. is seeing a recovery during this year of the pandemic and economic fallout as luxury conglomerate LVMH Moët Hennessy Louis Vuitton SE tries to dum…

Published

on

post featured image
ADVERTISEMENT

Tiffany & Co. is recovering from the pandemic and economic fallout as luxury conglomerate LVMH Moët Hennessy Louis Vuitton SE tries to dump the $16.2 billion acquisition of the jewelry chain.
Global net sales in the last two months only dropped a bit from a year ago and earnings based on 2019 data increased approximately 25%.
The company’s cash balance was in excess of $1 billion at September’s end – and the outlook for the end of the year will be approximately $900 million.
“While we st…

Click here to view the original article.

Business

GM Admits It Doesn’t Actually Have A Real, Working Hummer EV Yet – InsideEVs

Apparently, GM doesn’t have a concept Hummer EV. It’s working on one now, but the reveal was mostly (if not all) CGI, and the truck is a display model.

Published

on

post featured image
ADVERTISEMENT

General Motor’s GMC Hummer EV reveal was supposed to happen back in May. However, like many other events, it was delayed for many months due to the COVID-19 pandemic. When it finally happened this week, it wasn’t actually an event at all, and there was no real electric pickup truck.
There was no live stream, no electric pickup truck on a stage, no execs talking, nothing. Instead, GM played what appeared to be a 6-minute CGI video of the Hummer EV tackling tough terrain. The video ended, we waited…

Click here to view the original article.

Continue Reading

Business

Moderna’s stock gains 3.5% after it completes enrollment in COVID-19 vaccine trial – MarketWatch

Published

on

post featured image
ADVERTISEMENT

Shares of Moderna Inc.
MRNA,
+4.36%
gained 3.5% in trading on Thursday after it said it has completed enrollment of 30,000 participants in the Phase 3 clinical trial for its COVID-19 vaccine candidate. The trial is being conducted in partnership with the National Institutes of Health and the Biomedical Advanced Research and Development Authority. The preclinical company also said that 25,650 participants have received their second and final dose of the experimental vaccine in the late-stage trial,…

Click here to view the original article.

Continue Reading

Business

Why Align Technology Stock Is Skyrocketing Today – Motley Fool

The orthodontic-device maker delivered Q3 results that crushed expectations.

Published

on

post featured image
ADVERTISEMENT

What happened
Shares of Align Technology(NASDAQ:ALGN) were skyrocketing 32.9% higher as of 10:09 a.m. EDT on Thursday. The huge jump came after the orthodontic-device maker announced stellar third-quarter results after the market closed on Wednesday.
So what
Align didn’t merely beat analysts’ estimates in Q3; it absolutely crushed them. Wall Street expected the company to post revenue of around $514 million. Align generated revenue of $734.1 million in Q3. Analysts looked for adjusted earnings…

Click here to view the original article.

Continue Reading

Trending

You might also like ...

post featured image
September existing home sales jump 9.4%, but ‘prices are rising too fast’ as supply remains tight – CNBC
post featured image
Facebook adds hosting, shopping features, and pricing tiers to WhatsApp Business – TechCrunch
post featured image
Texas woman died of coronavirus on Spirit Airlines flight diverted to New Mexico, officials say – Fox News